Manufacturer of Controlled Substances; Notice of Registration, 69467-69468 [2010-28520]
Download as PDF
<![CDATA[
69467
Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices
Drug
Schedule
Benzoylecgonine (9180) ..............................................................................................................................................................................
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Varian Inc., to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Varian
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–28515 Filed 11–10–10; 8:45 am]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSKH9S0YB1PROD with NOTICES
VerDate Mar<15>2010
17:23 Nov 10, 2010
Schedule
Jkt 223001
II
II
The company plans to manufacture
the listed controlled substances as bulk
controlled substance intermediates for
distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Penick Corporation to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Penick Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
BILLING CODE 4410–09–P
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010, (75 FR 36683), Penick
Corporation, 33 Industrial Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in schedule II:
II
II
II
II
II
II
II
II
II
II
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
[FR Doc. 2010–28533 Filed 11–10–10; 8:45 am]
Manufacturer of Controlled
Substances; Notice of Registration
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Schedule
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
BILLING CODE 4410–09–P
Drug
Drug
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated June 17, 2010, and
published in the Federal Register on
June 28, 2010, (75 FR 36683), Wildlife
Laboratories, Inc., 1401 Duff Drive,
Suite 400, Fort Collins, Colorado 80524,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of Carfentanil (9743), a
basic class of controlled substance listed
in schedule II.
The company will manufacture the
above listed controlled substance for
sale to veterinary pharmacies, zoos, and
for other animal and wildlife
applications.
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
II
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Wildlife Laboratories, Inc. to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Wildlife Laboratories, Inc.
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2010–28522 Filed 11–10–10; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 16, 2010, and
published in the Federal Register on
March 24, 2010, (75 FR 14190),
Archimica, Inc., 2460 W. Bennett Street,
Springfield, Missouri 65807–1229, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Gamma Hydroxybutyric Acid (2010), a
basic class of controlled substance listed
in schedule I.
The company plans to manufacture
the listed controlled substance in bulk
for sale to its customers.
One comment and objection was
received. However, after a thorough
review of this matter, DEA has
concluded that the issues raised in the
comment and objection do not warrant
the denial of this application.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the
registration of Archimica, Inc., to
manufacture the listed basic class of
controlled substance is consistent with
E:\FR\FM\12NON1.SGM
12NON1
69468
Federal Register / Vol. 75, No. 218 / Friday, November 12, 2010 / Notices
the public interest at this time. DEA has
investigated Archimica, Inc. to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic class of controlled substance
listed.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
eligibility requirements of the Trade Act
of 1974, as amended.
Department of Labor’s prior decision is
appropriate.
Conclusion
Signed at Washington, DC, this 13th day of
August, 2010.
Del Min Amy Chen,
Certifying Officer, Office of Trade Adjustment
Assistance.
After careful review of the
application, I conclude that the claim is
of sufficient weight to justify
reconsideration of the U.S. Department
of Labor’s prior decision. The
application is, therefore, granted.
Signed at Washington, DC, this 13th day of
August, 2010.
Del Min Amy Chen,
Certifying Officer, Office of Trade Adjustment
Assistance.
[FR Doc. 2010–28491 Filed 11–10–10; 8:45 am]
BILLING CODE 4510–FN–P
Employment and Training
Administration
BILLING CODE 4410–09–P
[TA–W–73,756]
DEPARTMENT OF LABOR
Progressive Furniture, Inc., Including
On-Site Leased Workers From Onin
Staffing, a Subsidiary of Sauder
Furniture, Claremont, NC; Notice of
Affirmative Determination Regarding
Application for Reconsideration
Employment and Training
Administration
[TA–W–73,963]
mstockstill on DSKH9S0YB1PROD with NOTICES
Dentek.com, D/B/A Nsequence Center
for Advanced Dentistry; Reno, NV;
Notice of Affirmative Determination
Regarding Application for
Reconsideration
By application dated July 16, 2010, a
petitioner requested administrative
reconsideration of the negative
determination regarding workers’
eligibility to apply for Trade Adjustment
Assistance (TAA) applicable to workers
and former workers of the subject firm.
The determination was issued on June
22, 2010. The Department’s Notice of
Determination was published in the
Federal Register on July 7, 2010 (75 FR
39049). Workers are engaged in
employment related to the production of
dental prosthetics.
The initial determination was based
on the findings that worker separations
are not attributable to increased imports
of articles like or directly competitive
with dental prosthetics or a shift/
acquisition of these articles to a foreign
country by the workers’ firm.
In the request for reconsideration, the
petitioner provided additional
information regarding company imports
and operations.
The Department has carefully
reviewed the request for reconsideration
and the existing record and has
determined that the Department will
conduct further investigation to
determine if the workers meet the
VerDate Mar<15>2010
17:23 Nov 10, 2010
Jkt 223001
On July 19, 2010, the Department
issued a determination regarding
workers’ eligibility to apply for Trade
Adjustment Assistance (TAA)
applicable to workers and former
workers of the subject firm. The
Department’s Notice of Determination
was published in the Federal Register
on August 6, 2010 (75 FR 47635).
The initial investigation resulted in a
negative determination based on the
findings that there was no increase in
imports or shift to/acquisition from a
foreign country of decommissioning
services by the workers’ firm, and that
the workers’ firm did not produce an
article or supply a service that was used
by a firm with workers eligible to apply
for TAA in the production of an article
or supply of a service that was the basis
for TAA-certification.
Subsequent to the issuance of the
negative determination, the Department
was informed of a mistake in fact in the
case at hand.
Based on this new information, the
Department has determined that it is
appropriate for the Department to
conduct further investigation to
determine if the workers meet the
eligibility requirements of the Trade Act
of 1974, as amended.
Conclusion
After careful review, I conclude that
a reconsideration of the U.S.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
BILLING CODE 4510–FN–P
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–73,210; TA–W–73,210A]
Metlife Moosic, PA, Metlife Clarks
Summit, PA; Notice of Affirmative
Determination Regarding Application
for Reconsideration
DEPARTMENT OF LABOR
[FR Doc. 2010–28520 Filed 11–10–10; 8:45 am]
[FR Doc. 2010–28489 Filed 11–10–10; 8:45 am]
By application dated August 2, 2010,
the petitioners requested administrative
reconsideration of the negative
determination regarding workers’
eligibility to apply for Trade Adjustment
Assistance (TAA) applicable to workers
and former workers of the subject firm.
The determination was issued on July
14, 2010, and the Department’s Notice
of Determination was published in the
Federal Register on August 2, 2010 (75
FR 45163).
The initial investigation resulted in a
negative determination based on the
findings that there was no increase in
imports or acquisition from a foreign
country of software testing and quality
assurance services by the workers’ firm,
and that the workers’ firm did not
produce an article or supply a service
that was used by a firm with workers
eligible to apply for Trade Adjustment
Assistance (TAA) in the production of
an article or supply of a service that was
the basis for TAA-certification.
In the request for reconsideration, the
petitioners provided additional
information alleging the procurement by
the subject firm from foreign sources of
services like and directly competitive
with those produced by the petitioning
workers.
The Department has carefully
reviewed the request for reconsideration
and the existing record, and has
determined that the Department will
conduct further investigation to
determine if the workers meet the
eligibility requirements of the Trade Act
of 1974, as amended.
Conclusion
After careful review of the
application, I conclude that the claim is
of sufficient weight to justify
reconsideration of the U.S. Department
E:\FR\FM\12NON1.SGM
12NON1
]]>Agencies
[Federal Register Volume 75, Number 218 (Friday, November 12, 2010)]
[Notices]
[Pages 69467-69468]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-28520]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 16, 2010, and published in the Federal
Register on March 24, 2010, (75 FR 14190), Archimica, Inc., 2460 W.
Bennett Street, Springfield, Missouri 65807-1229, made application by
letter to the Drug Enforcement Administration (DEA) to be registered as
a bulk manufacturer of Gamma Hydroxybutyric Acid (2010), a basic class
of controlled substance listed in schedule I.
The company plans to manufacture the listed controlled substance in
bulk for sale to its customers.
One comment and objection was received. However, after a thorough
review of this matter, DEA has concluded that the issues raised in the
comment and objection do not warrant the denial of this application.
DEA has considered the factors in 21 U.S.C. 823(a) and determined
that the registration of Archimica, Inc., to manufacture the listed
basic class of controlled substance is consistent with
[[Page 69468]]
the public interest at this time. DEA has investigated Archimica, Inc.
to ensure that the company's registration is consistent with the public
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823, and in
accordance with 21 CFR 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic class of controlled
substance listed.
Dated: November 1, 2010.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2010-28520 Filed 11-10-10; 8:45 am]
BILLING CODE 4410-09-P
